TOP TIERMARKET NEWSWIRE
News & sentiment

EDITAS MEDICINE INC (EDIT) — News & AI sentiment

EDITAS MEDICINE INC (EDIT) news roundup. 2 stories in the past week, 13 over 30 days. Average 30-day sentiment is 60.3/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 4 sales totalling $21K — net selling of $21K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 61.5/100
30d stories
13
avg sentiment 60.3/100
Insider net (90d)
$21K
0 buys · 4 sells
Congress (90d)
0
0 buys · 0 sells

EDIT news in the last 24 hours, 7 days, 30 days and 90 days

How much EDIT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowEDIT storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days261.5/100EDIT headlines →
Last 30 days1360.3/100EDIT headlines →
Last 90 days3255.5/100EDIT headlines →

Latest stories on EDIT

5d ago
5d ago
Oct 14
Oct 14
Oct 12
Oct 8
Oct 8
Oct 8
Oct 8
Oct 8
Editas Medicine, Inc. (EDIT) files 8-K
SEC 8-K50 · neutralgeneral
Oct 8
Oct 8
Oct 8
Sep 23
Sep 23
Sep 23
Why is Editas Medicine stock rallying today?
Investing.com Markets50 · neutralgeneral
Sep 23
Guggenheim upgrades Editas Medicine stock rating on gene editing therapy
Investing.com Analyst Ratings61 · neutralanalyst
Sep 23
Sep 23
Sep 23
Sep 9
Sep 9
Sep 8
Sep 8
Sep 8
Open EDIT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →